Citi Reiterates Hold and PT of $36 on Dendreon

Citi reiterated its Hold rating on Dendreon DNDN. At the same time, the rating agency left its price target on the company's stock unchanged at $36. On Friday, Dendreon lost 0.87% of its value to finish the week at $38.80.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: ReiterationAnalyst RatingsBiotechnologyCitiHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!